IP Library Granted Patent US 6,858,707
Granted Patent B1
US 6,858,707 · App. 09/412,100 · Granted Feb 22, 2005

Hypersensitive response elicitor fragments which are active but do not elicit a hypersensitive response

Assignees: EDEN Bioscience Corporation; Cornell Research Foundation, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,858,707
App. No.
09/412,100
Granted
Feb 22, 2005
Kind
B1
Abstract

The present invention is directed to isolated active fragments of a hypersensitive response elicitor protein or polypeptide which fragment does not elicit a hypersensitive response in plants. Also disclosed are isolated DNA molecules which encode such fragments. Isolated fragments of hypersensitive response elicitor proteins or polypeptides in accordance with the present invention and the isolated DNA molecules that encode them have the following activities: imparting disease resistance to plants, enhancing plant growth, and/or controlling insects on plants. This can be achieved by applying the fragments of a hypersensitive response elicitor in a non-infectious form to plants or plant seeds under conditions effective to impart disease resistance, to enhance plant growth, and/or to control insects on plants or plants grown from the plant seeds. Alternatively, transgenic plants or plant seeds transformed with a DNA molecule encoding the fragment can be provided and the transgenic plants or plants resulting from the trasgenic plant seeds are grown under conditions effective to impart disease resistance, to enhance plant growth, and/or to control insects on plants or plants grown from the plant seeds.

Claims (32)

1. An isolated fragment of a hypersensitive response elicitor protein or polypeptide, wherein said fragment is selected from the group consisting of a C-terminal fragment of the amino acid sequence of SEQ ID NO: 23 consisting of the following amino acids of SEQ ID NO: 23: 169 to 403, 210 to 403, 267 to 403, or 343 to 403; an internal fragment of the amino acid sequence of SEQ ID NO: 23 consisting of the following amino acids of SEQ ID NO: 23: 150 to 179, 137 to 166, 121 to 150, 76 to 168, 105 to 168, or 137 to 156; and a fragment of the amino acid sequence of SEQ ID NO: 31 consisting of amino acids 190 to 294 of SEQ ID NO: 31.

2. An isolated fragment according to claim 1 , wherein the fragment is a C-terminal fragment of the amino acid sequence of SEQ ID NO: 23 consisting of the following amino acids of SEQ ID NO: 23: 169 to 403, 210 to 403, 267 to 403, or 343 to 403.

3. An isolated fragment according to claim 1 , wherein the fragment is an internal fragment of the amino acid sequence of SEQ ID NO: 23 consisting of the following amino acids of SEQ ID NO: 23: 150 to 179, 137 to 166, 121 to 150, 76 to 168, 105 to 168, or 137 to 156.

4. An isolated fragment according to claim 1 , wherein the fragment consists of amino acids 190 to 294 of SEQ ID NO: 31.

5. A method of imparting disease resistance to plants comprising:

administering a fragment of a hypersensitive response elicitor protein or polypeptide according to claim 1 in a non-infectious form to a plant or plant seed under conditions effective to impart disease resistance to the plant or a plant grown from the plant seed.

6. A method according to claim 5 , wherein plants are treated during said administering.

7. A method according to claim 5 further comprising:

planting the seeds treated with the fragment of the hypersensitive response elicitor in natural or artificial soil and

propagating plants from the seeds planted in the soil.

8. A method of enhancing plant growth comprising:

administering a fragment of a hypersensitive response elicitor protein or polypeptide according to claim 1 in a non-infectious form to a plant or plant seed under conditions effective to enhance plant growth of the plant or of a plant grown from the plant seed.

9. A method according to claim 8 , wherein plants are treated during said administering.

10. A method according to claim 8 further comprising:

planting the seeds treated with the fragment of the hypersensitive response elicitor in natural or artificial soil and

propagating plants from the seeds planted in the soil.

11. A method of insect control for plants comprising:

administering a fragment of a hypersensitive response elicitor protein or polypeptide according to claim 1 in a non-infectious form to a plant or plant seed under conditions effective to control insects.

12. A method according to claim 11 , wherein plants are treated during said administering.

13. A method according to claim 11 further comprising:

planting the seeds treated with the fragment of the hypersensitive response elicitor in natural or artificial soil and

propagating plants from the seeds planted in the soil.

14. An isolated fragment according to claim 2 , wherein the fragment has an amino acid sequence consisting of amino acids 169 to 403 of SEQ ID NO: 23.

15. An isolated fragment according to claim 2 , wherein the fragment has an amino acid sequence consisting of amino acids 210 to 403 of SEQ ID NO: 23.

16. An isolated fragment according to claim 2 , wherein the fragment has an amino acid sequence consisting of amino acids 267 to 403 of SEQ ID NO: 23.

17. An isolated fragment according to claim 2 , wherein the fragment has an amino acid sequence consisting of amino acids 343 to 403 of SEQ ID NO: 23.

18. An isolated fragment according to claim 3 , wherein the fragment has an amino acid sequence consisting of amino acids 150 to 179 of SEQ ID NO: 23.

19. An isolated fragment according to claim 3 , wherein the fragment has an amino acid sequence consisting of amino acids 137 to 166 of SEQ ID NO: 23.

20. An isolated fragment according to claim 3 , wherein the fragment has an amino acid sequence consisting of amino acids 121 to 150 of SEQ ID NO: 23.

21. An isolated fragment according to claim 3 , wherein the fragment has an amino acid sequence consisting of amino acids 76 to 168 of SEQ ID NO: 23.

22. An isolated fragment according to claim 3 , wherein the fragment has an amino acid sequence consisting of amino acids 105 to 168 of SEQ ID NO: 23.

23. An isolated fragment according to claim 3 , wherein the fragment has an amino acid sequence consisting of amino acids 137 to 156 of SEQ ID NO: 23.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Mar 23, 2010
From: EDEN BIOSCIENCE CORPORATION
To: PLANT HEALTH CARE, INC.
Reel/Frame 024120/0716 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2008
From: EDEN BIOSCIENCE CORPORATION
To: PLANT HEALTH CARE, INC.
Reel/Frame 020986/0492 →
SECURITY INTEREST Recorded Apr 24, 2007
From: PLANT HEALTH CARE, INC.
To: EDEN BIOSCIENCE CORPORATION
Reel/Frame 019204/0272 →
A CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE CITY RECORDED ON MAY 9, 2002 AT REEL 012889 FRAME 0927 Recorded Jun 8, 2004
From: BEER, STEVEN V.; LABY, RON J.
To: CORNELL RESEARCH FOUNDATION, INC.
Reel/Frame 015461/0542 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2002
From: BEER, STEVEN V.; LABY, RON J.
To: CORNELL RESEARCH FOUNDATION, INC.
Reel/Frame 012889/0927 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2002
From: STEPHENS, JENNIFER J.
To: EDEN BIOSCIENCE CORPORATION
Reel/Frame 012890/0277 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 22, 1999
From: WEI, ZHONG-MIN; FAN, HAO; NIGGEMEYER, JENNIFER J.
To: EDEN BIOSCIENCE CORPORATION
Reel/Frame 010407/0931 →
Continuity (1)
Provisional Application 6010305000 · Oct 5, 1998